Dyne Therapeutics (DYN) Invested Capital (2019 - 2026)

Dyne Therapeutics' Invested Capital history runs 8 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 51.73% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 51.73% YoY), while the FY2025 annual figure was $1.1 billion, up 77.99% from the prior year.
• Invested Capital was $1.0 billion for Q1 2026 at Dyne Therapeutics, down from $1.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.1 billion in Q4 2025 to a low of $91.3 million in Q4 2023.
• Historically, Invested Capital has averaged $510.2 million across 5 years, with a median of $478.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Invested Capital tumbled 63.83% in 2023, then surged 589.92% in 2024.
• A 5-year view of Invested Capital shows it stood at $252.4 million in 2022, then sank by 63.83% to $91.3 million in 2023, then soared by 589.92% to $629.8 million in 2024, then soared by 77.99% to $1.1 billion in 2025, then dropped by 9.45% to $1.0 billion in 2026.
• The last three Invested Capital figures came in at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $790.9 million (Q3 2025), per Business Quant data.